
        <!DOCTYPE html>
        <html>
        <head>
            <title>Rocket Pharmaceuticals Inc. (RCKT) - Articles</title>
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <style>
                :root {
                    --primary-color: #000000;
                    --secondary-color: #666666;
                    --accent-color: #d5001c;
                    --text-color: #2c3e50;
                    --border-color: #e0e0e0;
                    --hover-color: #f8f9fa;
                }
                
                body { 
                    font-family: "Porsche Next", "Segoe UI", Arial, sans-serif;
                    margin: 0;
                    padding: 0;
                    color: var(--text-color);
                    background-color: #f5f6fa;
                    line-height: 1.6;
                }
                
                .header {
                    background: linear-gradient(135deg, #000 0%, #1a1a1a 100%);
                    padding: 25px 0;
                    box-shadow: 0 2px 10px rgba(0,0,0,0.2);
                    position: sticky;
                    top: 0;
                    z-index: 1000;
                    backdrop-filter: blur(10px);
                }
                
                .header::before {
                    content: '';
                    position: absolute;
                    top: 0;
                    left: 0;
                    right: 0;
                    bottom: 0;
                    background: radial-gradient(circle at 30% 50%, rgba(255,255,255,0.08) 0%, rgba(255,255,255,0) 70%);
                    pointer-events: none;
                }
                
                .header-content {
                    max-width: 1400px;
                    margin: 0 auto;
                    padding: 0 30px;
                    display: flex;
                    justify-content: space-between;
                    align-items: center;
                }
                
                .header-title {
                    font-size: 28px;
                    font-weight: 300;
                    color: #fff;
                    margin: 0;
                    letter-spacing: 1px;
                }
                
                .back-btn {
                    background: rgba(255,255,255,0.1);
                    border: 1px solid rgba(255,255,255,0.2);
                    padding: 10px 20px;
                    color: #fff;
                    text-decoration: none;
                    font-size: 14px;
                    border-radius: 4px;
                    transition: all 0.3s ease;
                    backdrop-filter: blur(5px);
                }
                
                .back-btn:hover {
                    background: rgba(255,255,255,0.2);
                    transform: translateY(-2px);
                }
                
                .container {
                    max-width: 1400px;
                    margin: 40px auto;
                    padding: 0 30px;
                }
                
                .stats-container {
                    display: grid;
                    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
                    gap: 20px;
                    margin-bottom: 40px;
                }
                
                .stat-card {
                    background: #fff;
                    border-radius: 12px;
                    padding: 25px;
                    text-align: center;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: transform 0.3s ease;
                }
                
                .stat-card:hover {
                    transform: translateY(-5px);
                }
                
                .stat-value {
                    font-size: 32px;
                    font-weight: 300;
                    color: var(--primary-color);
                    margin-bottom: 10px;
                }
                
                .stat-label {
                    font-size: 14px;
                    color: var(--secondary-color);
                    text-transform: uppercase;
                    letter-spacing: 1px;
                }
                
                .articles-grid {
                    display: grid;
                    grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
                    gap: 30px;
                    margin-top: 40px;
                }
                
                .article-card {
                    background: #fff;
                    border-radius: 12px;
                    overflow: hidden;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: all 0.3s ease;
                }
                
                .article-card:hover {
                    transform: translateY(-5px);
                }
                
                .article-content {
                    padding: 25px;
                }
                
                .article-title {
                    font-size: 18px;
                    font-weight: 400;
                    margin: 0 0 15px;
                    line-height: 1.4;
                }
                
                .article-title a {
                    color: var(--primary-color);
                    text-decoration: none;
                    transition: color 0.2s ease;
                }
                
                .article-title a:hover {
                    color: var(--accent-color);
                }
                
                .article-meta {
                    display: flex;
                    align-items: center;
                    gap: 20px;
                    margin-bottom: 15px;
                    font-size: 14px;
                    color: var(--secondary-color);
                }
                
                .article-sentiment {
                    padding: 4px 12px;
                    border-radius: 20px;
                    font-weight: 500;
                    font-size: 14px;
                }
                
                .article-sentiment.positive {
                    background: rgba(40,167,69,0.1);
                    color: #28a745;
                }
                
                .article-sentiment.negative {
                    background: rgba(220,53,69,0.1);
                    color: #dc3545;
                }
                
                .article-sentiment.neutral {
                    background: rgba(108,117,125,0.1);
                    color: #6c757d;
                }
                
                .article-summary {
                    font-size: 14px;
                    color: var(--text-color);
                    line-height: 1.6;
                    margin-top: 15px;
                    opacity: 0.8;
                }
                
                @media (max-width: 768px) {
                    .header-content {
                        padding: 0 20px;
                    }
                    
                    .header-title {
                        font-size: 20px;
                    }
                    
                    .container {
                        padding: 0 20px;
                        margin: 20px auto;
                    }
                    
                    .articles-grid {
                        grid-template-columns: 1fr;
                        gap: 20px;
                    }
                    
                    .stat-card {
                        padding: 20px;
                    }
                    
                    .stat-value {
                        font-size: 28px;
                    }
                }
            </style>
        </head>
        <body>
            <div class="header">
                <div class="header-content">
                    <h1 class="header-title">Rocket Pharmaceuticals Inc. (RCKT)</h1>
                    <a href="sentiment_report_latest.html" class="back-btn">← Back to Dashboard</a>
                </div>
            </div>
            
            <div class="container">
                <div class="stats-container">
                    <div class="stat-card">
                        <div class="stat-value">29</div>
                        <div class="stat-label">Total Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">4</div>
                        <div class="stat-label">Positive Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">10</div>
                        <div class="stat-label">Negative Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">-0.11</div>
                        <div class="stat-label">Average Sentiment</div>
                    </div>
                </div>
                
                <div class="articles-grid">
        
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=66ab6786a5d243e3835a94eb9e010667e94e9dc5b0806aec10de3d15a1292869" target="_blank" rel="noopener noreferrer">Top FDA Official’s Surprise Departure Means More Uncertainty for Biotech</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.87
                                </span>
                            </div>
                            <div class="article-summary">Biotech investors seemed to be taking the sudden departure of a top Food and Drug Administration official late Tuesday as a good sign for the sector, but increasing turmoil at the FDA could worsen the...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1a79d9bd4794308757b3d44d88dc088b23f9ca0dfbd48df5e6d6ffec249de5e4" target="_blank" rel="noopener noreferrer">Rocket lays off staff; Abivax capitalizes on immune drug data</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-24</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.96
                                </span>
                            </div>
                            <div class="article-summary">The gene therapy developer is cutting 30% of its workforce. Elsewhere, Abivax secured a major cash infusion, while Novartis and Eli Lilly struck small research deals....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=3b19915dee8363269138fefb4412c7280264ce367bdb6555b9ffa88af336dde8" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-24</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.55
                                </span>
                            </div>
                            <div class="article-summary">CRANBURY, N.J., July 24, 2025--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorder...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=bacc89656a331532d480b52fb9ce6619f58f6a92084f10d2c71719bc3c702f3d" target="_blank" rel="noopener noreferrer">Sector Update: Health Care Stocks Softer in Afternoon Trading</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-24</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.94
                                </span>
                            </div>
                            <div class="article-summary">Health care stocks declined Thursday afternoon, with the NYSE Health Care Index and the Health Care...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=afd3eebee599491a29d61a9f93d46d85df91c93faa3c1ce879c2ec9fc19142e6" target="_blank" rel="noopener noreferrer">RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-18</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.88
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals jumps 16.8% as FDA grants RMAT status to RP-A601 on positive phase I heart disease data....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a1ee77612761cff4dc3cf76cd06b44a2f8361a1022525cba90c37e29ee0d7350" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-17</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.93
                                </span>
                            </div>
                            <div class="article-summary">CRANBURY, N.J., July 17, 2025--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorder...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=64d59a2af2e59cbff5674b2470b0121bc543902c8ef16dabd0be13237a8bd992" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-16</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.29
                                </span>
                            </div>
                            <div class="article-summary">BENSALEM, Pa., July 16, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4a4b028b2503991ddd790beb5cbb8a334f2ba637a16729ea23c66d709efec8b5" target="_blank" rel="noopener noreferrer">Levi & Korsinsky Reminds Rocket Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-15</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.44
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, July 15, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=865d35fcc702e9f6b512d52bd758e2871495d2671a98590eede90d8032d79cad" target="_blank" rel="noopener noreferrer">Faruqi & Faruqi Reminds Rocket Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-15</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their OptionsIf you purchased or.....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=8ad222348f3af64a83ab55e7c3cd42ad24a49d30bfbca3a153678f4c9115aaef" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals Receives FDA IND Clearance for BAG3-DCM Gene Therapy RP-A701</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-15</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.36
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best low priced pharma stocks to buy now. On June 30, Rocket Pharmaceuticals announced that the US FDA cleared its Investigational New Drug/IND ...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=2e916389072d86ea0acc16bb87a7d01f94194953d3419a212c15b73be9a468dc" target="_blank" rel="noopener noreferrer">ATTENTION NASDAQ: RCKT INVESTORS</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-15</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.31
                                </span>
                            </div>
                            <div class="article-summary">PHILADELPHIA, July 15, 2025 /PRNewswire/ -- Berger Montague PC, a nationally recognized securities litigation firm based in Philadelphia, announces it is investigating a newly filed securities class.....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=2afc43d0ba4ced4ea8b8b73dd45a7e465697d1ff47628709a1f1877d04dd89f4" target="_blank" rel="noopener noreferrer">Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-15</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who.....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5463a64ca88eb98799eabaf44ac2f711d42bf72ccec4295e33729b8395f12774" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc. Class Action: The Gross Law Firm Reminds Rocket Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-14</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, July 14, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. . ......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b5eaf4a73f78eb169e99fb80845474b499afc88c0bd00b771eb19f866b42eb37" target="_blank" rel="noopener noreferrer">RCKT LAWSUIT ALERT: Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-14</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.33
                                </span>
                            </div>
                            <div class="article-summary">Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who.....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c672c67defa76d25db0cd3cbecadb14834b9e49003af9279589e9532af603aa2" target="_blank" rel="noopener noreferrer">Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-12</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.69
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, July 12, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. . Such investors are advised to contact Danielle......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=81d03c38db1d81f197f6b82cc6827134b2832395ba5a606a2f0c75d33db17a7d" target="_blank" rel="noopener noreferrer">RCKT Investors Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-12</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, July 12, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0482a3a1bc4c73c9b248643ac4c3dd4cf0f019c2804ea0a36e9a148c569e1728" target="_blank" rel="noopener noreferrer">Shareholders that lost money on Rocket Pharmaceuticals, Inc.(RCKT) should contact Levi & Korsinsky about pending Class Action - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-11</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.44
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, July 11, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=40dfadab8edc44236c654a1c52d0ccb479121cdbe4a7625b69fb5bdd2b286f2b" target="_blank" rel="noopener noreferrer">August 11, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-11</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who.....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=fbad269e9754b87801f0ae8ef3f377d2fd21470a370f0a4d0d55dd05d6469a36" target="_blank" rel="noopener noreferrer">Contact The Gross Law Firm by August 11, 2025 Deadline to Join Class Action Against Rocket Pharmaceuticals, Inc.(RCKT)</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-10</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, July 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. . ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ba5b55c30ca8108e27b4d59082869a4cbb087091b6e5f9359690095d65861adb" target="_blank" rel="noopener noreferrer">Danon Disease Treatment Modality Market Analysis and Forecasts 2025-2035 | Next-Gen Sequencing Speeds Up Danon Disease Diagnosis and Treatment Pathways</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Danon disease, a rare X-linked dominant disorder due to LAMP2 gene mutations, primarily affects males, causing cardiomyopathy, skeletal myopathy, and cognitive issues. Advancements in NGS, whole exome...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=25aa25da116cfd86819650034522ecb615e74b69879193630173af95498dea39" target="_blank" rel="noopener noreferrer">Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-09</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who.....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=26324dd6a6119741c269ae122136ebb83e70511972645868d9361386c85f359a" target="_blank" rel="noopener noreferrer">Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-09</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.67
                                </span>
                            </div>
                            <div class="article-summary">PHILADELPHIA, July 9, 2025 /PRNewswire/ -- Berger Montague PC, a nationally recognized securities litigation firm based in Philadelphia, announces it is investigating a newly filed securities class......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f95aedfb38ab802721ee21b30416866641a9eff9d67686b984f0819c095a097d" target="_blank" rel="noopener noreferrer">Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Lawsuit - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-08</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who.....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=77f8583fbb66e95673861eb1d391ca13b0b97fe12be1cdf23a8ef31c0de3b758" target="_blank" rel="noopener noreferrer">RCKT Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-08</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0bd267164150c56134222dbae14cce631e08d29676c3e13a6fa1307257505d5c" target="_blank" rel="noopener noreferrer">The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Lawsuit - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-07</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, July 7, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. . ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5c010c070c4a03ae3eaf814b2d7aace1251e3a6fbd388e6c13b613ddbc1d46f4" target="_blank" rel="noopener noreferrer">Investors in Rocket Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-07</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who.....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=3b33eb52e97bd3dcc87dee190bdbbd0a36155fab9ac6be8eda164940c87f2261" target="_blank" rel="noopener noreferrer">SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-03</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their OptionsIf you purchased......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1b67c2331a97ceaffe812e3b7e0cabf8dd0b5cbf32afaaa529093958263ed1d0" target="_blank" rel="noopener noreferrer">Investors in Rocket Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before August 11, 2025 to Discuss Your Rights - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-03</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, July 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. . ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=496dce2a2a48c301bb637954e4bf3ecf5cf3dfdf5e26f922b94799796898057d" target="_blank" rel="noopener noreferrer">Shareholders That Lost Money on Rocket Pharmaceuticals, Inc. (RCKT) Should Contact Levi & Korsinsky About Pending Class Action - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-02</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who.....</div>
                        </div>
                    </div>
            
                </div>
            </div>
        </body>
        </html>
        